Mucosal vaccination and immune responses in the elderly

Vaccine. 2000 Feb 25;18(16):1675-80. doi: 10.1016/s0264-410x(99)00505-8.

Abstract

To develop a mucosal vaccine strategy for the elderly, we have compared mucosal and systemic immune responses between aged (12-14 months) and young adult (8-12 weeks) mice. Both aged and young mice were immunized weekly with three oral doses of 1 mg of ovalbumin (OVA) and 10 microg of cholera toxin as adjuvant. Although elevated levels of OVA-specific systemic IgG and mucosal IgA Ab responses were seen in young mice, aged mice showed impaired antigen-specific mucosal and systemic immune responses. These results suggest that mucosal immunity is down regulated in aged mice.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Administration, Oral
  • Aging / immunology*
  • Animals
  • B-Lymphocytes / immunology
  • Bacterial Toxins / administration & dosage
  • Cholera Toxin / administration & dosage
  • Enterotoxins / administration & dosage
  • Escherichia coli Proteins*
  • Immunity, Mucosal*
  • Immunoglobulin A / biosynthesis
  • Immunoglobulin G / biosynthesis
  • Mice
  • Ovalbumin / administration & dosage
  • Ovalbumin / immunology
  • Th1 Cells / immunology
  • Th2 Cells / immunology
  • Vaccination / methods*

Substances

  • Adjuvants, Immunologic
  • Bacterial Toxins
  • Enterotoxins
  • Escherichia coli Proteins
  • Immunoglobulin A
  • Immunoglobulin G
  • Ovalbumin
  • Cholera Toxin
  • heat-labile enterotoxin, E coli